| Tag | Content |
|---|
EnhancerAtlas ID | HS091-06195 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr10:101907630-101909780 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| CEBPA | MA0102.3 | chr10:101908325-101908336 | TATTATGCAAT | - | 6.02 | | EBF1 | MA0154.3 | chr10:101908744-101908758 | AATCCCCAGGGAAC | + | 6.26 | | Foxd3 | MA0041.1 | chr10:101907875-101907887 | GTTTGTTTGTTT | + | 6.32 | | HES2 | MA0616.2 | chr10:101908013-101908023 | GGCACGTGCC | + | 6.02 | | HES2 | MA0616.2 | chr10:101908013-101908023 | GGCACGTGCC | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09729 | chr10:101908189-101909651 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr10 | 101908352 | 101908679 | | chr10 | 101908207 | 101909030 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH10I100148 | chr10 | 101908041 | 101909781 |
|
Enhancer Sequence | TCCAAAATGC TGGGATTACA GGTGTGAGCC ACCGAGCCCC ACTGGAAGAA GACATTTTTT 60
AAAATTAAAA AAAAAAAAAG TAGAAAAATT GATTGAAAGA AATAAGAAAA ATTGGAAAGA 120
CAGGTACTAA TTCAGAAGAA ATATGGTAAG GGAAACAAGT AAAACGTCAT TCTGCATTAC 180
AGTCTATGTC AAAATAGACA CTAGGAGTGA GCAATGAATT AACAGTAAAT TTTTTGTTTT 240
TTTTTGTTTG TTTGTTTTGA GACAGAGTCT TGCTCTGTCG CCCAGCCTGG AGTGCAGTGG 300
CTCGATCTCA GCTCACTACA ACCTCCACCT CCCAGGTTCA AGTGATTCTC CTGCCTCAGC 360
CTCCTGAGTA GCTGGGGATT ATAGGCACGT GCCACCACAC CCAGCTAATT TTTGTATTTT 420
TAGTAGAGAT GAGGTTTCAC CATGTTGATC AGGCTGGTCT TGAGCTCCTG ACCTCATGAT 480
CTGACCGCCT CAGCCTCCCA AAGTGCTGGG ATTACAGGCA TGAACCACTG CACCCGGCCC 540
AGTAAATTCA TTTTAAGTGC TCATACCAGG GCAGAGACCA GGAGAAAGAT GAGAAGCTGG 600
CCCAGCTTGT TGGGATGCTC CTGGAGGGCT GTGGTTGGGG TTTAACATCC AGCTAGCTTA 660
GCTCATAGCT GGTGAAGACA TTAATCTACG TGTTCTATTA TGCAATTGCA GGTAGCAGGC 720
ACTGTGCTCA CTCTCTCCAC TATGGGAACT TATAGCTACT CAGAGACAGA CACATATATT 780
GACTCCTGTA GACAACTGAC TCCTGTAGAC AAGGTGAACT AATGCATCCC AGCAATTACC 840
ACGTGCGAAT CTCTACACTA GATGCAACAA CATATCCTCC TGAATCCACT GAAGAGTCAC 900
CCTGCAAGGA TGAGTAATCA GGTTCAGAGA TGTTAGGTAA CTTCCCATGG TTACACATAA 960
AGTCCTGACA TGGACACTGT AGGCTCACTT CTAAGTTTTT TCCATGACTC ACTTGCCTGA 1020
TTTACCTGCA TGTCATATTC AACTTTTTGT TCTTTCATGC AACAAAGCCA TCTCATATGG 1080
GCCAGATGCC ATCTTAGGCA TTAGCAACAG AAACAATCCC CAGGGAACAG CACAGCCACA 1140
GCCCCCGCCC CCGCCCTCAG AGAGATTAGC ATTTGTGAAA ACAGACATTG AGCACATAAT 1200
GAGACATGAA GTGTGCATGA TGTGTGACGG GGGGGAAATA CAGGATGCTA ACCCAGGCCA 1260
AGCAGTTCAA AGTGAACTGA AGCTTTTACA TCTGAAGAAG TGATGAAGAC TCAGGAGTTG 1320
GCTGAGGAAA GTCAGCACTA CGAGGGAAGG AAAGTGAACC AGGCAGATGG AACAACGTAT 1380
GAGAAGGGAC AGACAGAAGG TGCATTCAGG GACCTTAGAG AAGGGTGGCT GGAGAGGACA 1440
GCAGGGGCCA GATCACGAAC TTCGTGTGTA CACATTTGAG ACTTAATCCT AAAGCGATTA 1500
GAAGCCACGG CTTCTAATTC ACAAATTCTT TTGCCACAGA AGAGGCAGAA ATCACTTCAT 1560
TTTAATACCT ACCAATAACC TATAGGATGG TCAGTTCAAA TTATTCTCAG GTCCACAGCA 1620
ACTGACCTAG GATACTATGG GGTTGATCCC ATAAGAACAG GAGGAAAGAG CTGCTTTCCC 1680
CACAACTCCC ATTACCACTC CCTGCTGGCC CAAGATCACC AGGAAATTGA TCCCAGGAGG 1740
AAATACAGAA CGTTTGGGAA GAGCAGGTCC AACTCTGGCT CTTGGGCCGC TAACATCTTA 1800
ATAGTCAAGT TGGTTATATT GTGCCATTAC ATTACCAGTT ATAATTTACA CAAATTGTCC 1860
TTCTCTGGCT TGGTCTGTCT CCTCCCCTCC TCAGTGCAGA AGTACTTTTG CTCTCAGGGA 1920
CGGATCCCAG TGGCCTGATG CTCCATCCTC CCTCCTTGCC CCTCTGCCAC AGGCCCTGTC 1980
CCACAAAGGA TTAGAAGAAC ACCCCTTGTT AAATTCCAGG AGTCAGCAAA GAGTGGACAC 2040
CTTGTTTTAA ACATTCTTAT ACCAGGTAGG CAGTATTCTG GCAAGAGTAT AACAAAAGCC 2100
TCTACAGTTA AGTTAAACCC GCAAATAAAC TGGCTCCCTA GTTGAAATGT 2150
|
